Pharmafile Logo

Claire Long

Novartis building

Novartis says Cosentyx is ‘outpacing competitors’

Claims new psoriasis drug has almost a third of the market share in Germany alone

- PMLiVE

FDA advisors back Novo Nordisk’s IDeglira combination

Unanimous vote is a step forward for the Tesiba-Victoza injection

National Institute for Health and Care Excellence NICE logo

NICE backs freer use of SGLT2 inhibitors for diabetes

Recommendation positions Invokana, Forxiga and Jardiance as first-line treatments

Flexible content checklist – five questions to ask

To ensure that your content gets used by local markets and has a real impact, consider these questions when commissioning or developing core materials.

Anthill Agency

Merck holds global ‘tweet-a-thon’ on World MS Day

The German company's initiative involves employees from over 20 countries

- PMLiVE

Experience design of physical spaces: a human-centred approach

Anna Tamasi from Blue Latitude Health highlights the key considerations and best practices for spatial design from a user experience design perspective.

Blue Latitude Health

- PMLiVE

Otsuka joins its Japanese peers on Twitter

The firm's US operations make their social media debut

- PMLiVE

Virgo Health Education builds London office team

Victoria Thomas, Rachel Hassan, Arnika Paranjape and Harry O’Connor join

- PMLiVE

Creating an engaging experience for patients

The patient experience is inextricably connected to how HCPs feel about their work and are measured and perceived, and that experience is no longer limited to the 15-minute office visit....

- PMLiVE

Pegasus joins Ashfield Healthcare Communications

Acquired by UDG Healthcare in “strategically important” £16.8m deal

Boehringer Ingelheim headquarters

Boehringer crowdsources psychiatric research team

Collaboration with BioMed X aims to identify new treatment approaches

Sanofi Pascale Witz

Sanofi’s diabetes head Pascale Witz to leave the company

She will be replaced by Peter Guenter as part of an executive reshuffle

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links